Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Public ClinicalTrials.gov record NCT00790036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Study identification
- NCT ID
- NCT00790036
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 742 participants
Conditions and interventions
Conditions
Interventions
- Everolimus Drug
- Everolimus Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 23, 2009
- Primary completion
- Jun 14, 2016
- Completion
- Jun 14, 2016
- Last update posted
- Jul 11, 2017
2009 – 2016
United States locations
- U.S. sites
- 34
- U.S. states
- 21
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer and Research Centers SC | Chandler | Arizona | 85224 | — |
| Highlands Oncology Group Dept of Highlands Oncology Grp | Fayetteville | Arkansas | 72703 | — |
| University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (3) | La Jolla | California | 92093-0658 | — |
| USC/Kenneth Norris Comprehensive Cancer Center Dept.ofNorrisMedicalCenter(4) | Los Angeles | California | 90033 | — |
| University of Colorado Health | Colorado Springs | Colorado | 80909 | — |
| Denver Health & Hospital Authority CACZ885M2301 | Denver | Colorado | 80204-4507 | — |
| Rocky Mountain Cancer Centers RMCC | Greenwood Village | Colorado | — | — |
| University Cancer Institute | Boynton Beach | Florida | 33426 | — |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | — |
| Columbus Regional | Columbus | Georgia | 31904 | — |
| Rush University Medical Center Div. of Hematology & Oncology | Chicago | Illinois | 60612 | — |
| Indiana University Hospital IU Cancer Center | Indianapolis | Indiana | 46202 | — |
| Tulane University Health Sciences Center Office of Clinical Research | New Orleans | Louisiana | 70112 | — |
| Lahey Clinic Dept of Lahey Clinic (3) | Burlington | Massachusetts | 01805 | — |
| Mayo Clinic - Rochester Dept. of MayoClinic-Rochester | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine Div. of Medical Oncology | St Louis | Missouri | 63110 | — |
| Dartmouth Hitchcock Medical Center Dartmouth | Lebanon | New Hampshire | 03756 | — |
| Levine Cancer Institute Oncology | Charlotte | North Carolina | 28203 | — |
| Wake Forest University Baptist Medical Center Dept. of WFUHS | Winston-Salem | North Carolina | 27157 | — |
| University of Pittsburgh Medical Center SC-3 | Pittsburgh | Pennsylvania | 15213 | — |
| Medical University of South Carolina -Hollings Cancer Center MUSC/HCC (2) | Charleston | South Carolina | 29425 | — |
| Cancer Centers of the Carolinas Cancer Centers of Carolinas (3 | Greenville | South Carolina | 29605 | — |
| University of Tennessee Cancer Institute SC-2 | Memphis | Tennessee | 38104 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| The Center for Cancer and Blood Disorders Dept. of The Ctr for C & BD | Fort Worth | Texas | 76104 | — |
| University of Texas/MD Anderson Cancer Center Dept of MD Anderson (18) | Houston | Texas | 77030-4009 | — |
| Baylor College of Medicine Dept.of Baylor College of Med. | Houston | Texas | 77030 | — |
| South Texas Oncology and Hematology, PA South Texas Oncology (2) | San Antonio | Texas | 78258 | — |
| Texas A&M HealthSciencesCtr-Scott & White Memorial Hospital CenterForCancerPrevention&Care | Temple | Texas | 76508 | — |
| University of Vermont Office of Clinical Trials Res. | Burlington | Vermont | 05404 | — |
| University of Virginia Health Systems SC-2 | Charlottesville | Virginia | 22908-0334 | — |
| Blue Ridge Research Center at Roanoke Neurological Center SC | Roanoke | Virginia | 24018 | — |
| Dean Health System | Madison | Wisconsin | 53717 | — |
| Waukesha Memorial Hospital Cancer Center Dept.ofWaukeshaMemorialHosp. | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 168 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00790036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2017 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00790036 live on ClinicalTrials.gov.